Prediction of gestational diabetes mellitus by unconjugated estriol levels in maternal serum

Junguk Hur, Eun Hee Cho, Kwang Hyun Baek, Kyung Ju Lee

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The aim of this study was to evaluate the association between maternal serum estriol levels, which are routinely measured in the first trimester of pregnancy, and adverse pregnancy outcomes including gestational diabetes. We performed a retrospective chart analysis of women who delivered between July 1, 2007, and December 31, 2009, at Kangnam CHA Medical Center in Seoul, Korea. Only patients with available estriol measurements during their pregnancies and complete follow-up data were included in the study. The effect of estriol on the incidence of adverse pregnancy outcomes was examined using multinomial logistic regression analysis with age and pre-pregnancy body mass index (BMI) as covariates. The total number of subjects was 1,553, the mean age was 32.9 ± 3.7 years, and the mean pre-pregnancy BMI was 21.2 ± 3.0 kg/m2. Unconjugated estriol > 95th percentile of the screened population or unconjugated estriol ≥ 2.0 MoM (Multiple of the Median) was significantly associated with an increased risk for developing gestational diabetes mellitus (GDM), after adjusting for age and pre-pregnancy maternal weight. High levels of unconjugated estriol in the maternal serum during the early second trimester of pregnancy are a useful predictor of GDM development.

Original languageEnglish (US)
Pages (from-to)123-127
Number of pages5
JournalInternational Journal of Medical Sciences
Volume14
Issue number2
DOIs
StatePublished - Feb 7 2017
Externally publishedYes

Fingerprint

Estriol
Gestational Diabetes
Mothers
Serum
Pregnancy
Pregnancy Outcome
Body Mass Index
Second Pregnancy Trimester
First Pregnancy Trimester
Korea
Logistic Models
Regression Analysis
Weights and Measures
Incidence
Population

Keywords

  • Estriol
  • Gestational diabetes
  • Pregnancy outcomes

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Prediction of gestational diabetes mellitus by unconjugated estriol levels in maternal serum. / Hur, Junguk; Cho, Eun Hee; Baek, Kwang Hyun; Lee, Kyung Ju.

In: International Journal of Medical Sciences, Vol. 14, No. 2, 07.02.2017, p. 123-127.

Research output: Contribution to journalArticle

Hur, Junguk ; Cho, Eun Hee ; Baek, Kwang Hyun ; Lee, Kyung Ju. / Prediction of gestational diabetes mellitus by unconjugated estriol levels in maternal serum. In: International Journal of Medical Sciences. 2017 ; Vol. 14, No. 2. pp. 123-127.
@article{ffa3c895319140c3ae3b3c74e79eb4be,
title = "Prediction of gestational diabetes mellitus by unconjugated estriol levels in maternal serum",
abstract = "The aim of this study was to evaluate the association between maternal serum estriol levels, which are routinely measured in the first trimester of pregnancy, and adverse pregnancy outcomes including gestational diabetes. We performed a retrospective chart analysis of women who delivered between July 1, 2007, and December 31, 2009, at Kangnam CHA Medical Center in Seoul, Korea. Only patients with available estriol measurements during their pregnancies and complete follow-up data were included in the study. The effect of estriol on the incidence of adverse pregnancy outcomes was examined using multinomial logistic regression analysis with age and pre-pregnancy body mass index (BMI) as covariates. The total number of subjects was 1,553, the mean age was 32.9 ± 3.7 years, and the mean pre-pregnancy BMI was 21.2 ± 3.0 kg/m2. Unconjugated estriol > 95th percentile of the screened population or unconjugated estriol ≥ 2.0 MoM (Multiple of the Median) was significantly associated with an increased risk for developing gestational diabetes mellitus (GDM), after adjusting for age and pre-pregnancy maternal weight. High levels of unconjugated estriol in the maternal serum during the early second trimester of pregnancy are a useful predictor of GDM development.",
keywords = "Estriol, Gestational diabetes, Pregnancy outcomes",
author = "Junguk Hur and Cho, {Eun Hee} and Baek, {Kwang Hyun} and Lee, {Kyung Ju}",
year = "2017",
month = "2",
day = "7",
doi = "10.7150/ijms.17321",
language = "English (US)",
volume = "14",
pages = "123--127",
journal = "International Journal of Medical Sciences",
issn = "1449-1907",
publisher = "Ivyspring International Publisher",
number = "2",

}

TY - JOUR

T1 - Prediction of gestational diabetes mellitus by unconjugated estriol levels in maternal serum

AU - Hur, Junguk

AU - Cho, Eun Hee

AU - Baek, Kwang Hyun

AU - Lee, Kyung Ju

PY - 2017/2/7

Y1 - 2017/2/7

N2 - The aim of this study was to evaluate the association between maternal serum estriol levels, which are routinely measured in the first trimester of pregnancy, and adverse pregnancy outcomes including gestational diabetes. We performed a retrospective chart analysis of women who delivered between July 1, 2007, and December 31, 2009, at Kangnam CHA Medical Center in Seoul, Korea. Only patients with available estriol measurements during their pregnancies and complete follow-up data were included in the study. The effect of estriol on the incidence of adverse pregnancy outcomes was examined using multinomial logistic regression analysis with age and pre-pregnancy body mass index (BMI) as covariates. The total number of subjects was 1,553, the mean age was 32.9 ± 3.7 years, and the mean pre-pregnancy BMI was 21.2 ± 3.0 kg/m2. Unconjugated estriol > 95th percentile of the screened population or unconjugated estriol ≥ 2.0 MoM (Multiple of the Median) was significantly associated with an increased risk for developing gestational diabetes mellitus (GDM), after adjusting for age and pre-pregnancy maternal weight. High levels of unconjugated estriol in the maternal serum during the early second trimester of pregnancy are a useful predictor of GDM development.

AB - The aim of this study was to evaluate the association between maternal serum estriol levels, which are routinely measured in the first trimester of pregnancy, and adverse pregnancy outcomes including gestational diabetes. We performed a retrospective chart analysis of women who delivered between July 1, 2007, and December 31, 2009, at Kangnam CHA Medical Center in Seoul, Korea. Only patients with available estriol measurements during their pregnancies and complete follow-up data were included in the study. The effect of estriol on the incidence of adverse pregnancy outcomes was examined using multinomial logistic regression analysis with age and pre-pregnancy body mass index (BMI) as covariates. The total number of subjects was 1,553, the mean age was 32.9 ± 3.7 years, and the mean pre-pregnancy BMI was 21.2 ± 3.0 kg/m2. Unconjugated estriol > 95th percentile of the screened population or unconjugated estriol ≥ 2.0 MoM (Multiple of the Median) was significantly associated with an increased risk for developing gestational diabetes mellitus (GDM), after adjusting for age and pre-pregnancy maternal weight. High levels of unconjugated estriol in the maternal serum during the early second trimester of pregnancy are a useful predictor of GDM development.

KW - Estriol

KW - Gestational diabetes

KW - Pregnancy outcomes

UR - http://www.scopus.com/inward/record.url?scp=85012024709&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85012024709&partnerID=8YFLogxK

U2 - 10.7150/ijms.17321

DO - 10.7150/ijms.17321

M3 - Article

VL - 14

SP - 123

EP - 127

JO - International Journal of Medical Sciences

JF - International Journal of Medical Sciences

SN - 1449-1907

IS - 2

ER -